Episodit
-
In this episode of Neuro Innovation Talks, Head of Global Strategic Marketing and Strategic Relationships at Johnson & Johnson MedTech Neurovascular, John Murray, returns to the DeviceTalks podcast studio to spotlight one of the foremost pioneers in neurointervention, Fernando Vinuela, MD, Professor Emeritus of UCLA Interventional Neuroradiology. Dr. Vinuela shares his journey through the groundbreaking evolution of neurovascular treatments and the collaborative spirit that propelled early advancements in stroke care.
From his foundational work on detachable coils to his transformative mentorship, Dr. Vinuela reflects on his contributions to neurointervention and the significant milestones that have shaped the field. He also provides insights into his impactful work in Brazil, where he has helped establish stroke treatment programs, expanding the reach of life-saving neurovascular care.
Thank you to Confluent Medical Technologies for sponsoring this episode of Neuro Innovation Talks. To learn more about how Confluent Medical supports medical device companies, visit: https://confluentmedical.com.
Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Dr. Vinuela, Dr. Satoshi Tateshima, Dr. Dileep Yavagal.
Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode.
Thank you for supporting the Neuro Innovation Talks podcast! -
In this episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker tackle some of the weeks’ biggest news including the FDA giving a nod to Distalmotion’s Dexter robot and the Yankees blowing the World Series.
Distalmotion CEO Greg Roche visits to share his thoughts on both. Then Tom interviews Chad Hoskins, CEO of Phagenesis, a startup developing a neurostimulation device that could help stroke survivors recover.
This week’s Newmaker’s Newsmakers include Medtronic, Masimo, Exactech, Solventum and you already know about this week’s number one.
This episode is sponsored by DeviceTalks Boston. Register now at Boston.DeviceTalks.com.
Thanks for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode. -
Puuttuva jakso?
-
In this episode of IntuitiveTalks, Dirk Barten, Senior VP and GM of EU Commercial and Marketing at Intuitive, takes us through Europe's unique surgical robotics landscape. He discusses the differences in adoption rates between the US and Europe, where surgical robotics uptake has lagged by about five to seven years.
Barten also explains the critical role Intuitive’s digital ecosystem plays in supporting surgeons and healthcare teams throughout Europe. Through tools like tele-education and digital hubs, Intuitive is providing accessible training and data support, which he believes are essential in driving improved patient outcomes and meeting hospitals' needs for more integrated and efficient surgical solutions.
In addition, Barten explores how healthcare system consolidation in major European countries is reshaping hospital networks, leading to increased centralization of complex procedures. He highlights Intuitive’s investment in expanding its infrastructure across Europe, with new sites in Switzerland, Germany, and the UK, underscoring Intuitive’s confidence in the region’s growth potential despite ongoing economic pressures.
Thank you to Kollmorgen for sponsoring this episode. To learn more about how Kollmorgen works with medical device companies, please visit: www.kollmorgen.com.
And that’s not all! Explore some of Kollmorgen’s success stories below:
1. Kollmorgen and Stereotaxis Advance the Precision and Safety of Surgical Robots | https://www.kollmorgen.com/en-us/case-studies/kollmorgen-and-stereotaxis-advance-precision-and-safety-surgical-robots
2. Enabling New Surgical Possibilities with High-Torque, Low-Temperature and Compact-Size Motors | https://www.kollmorgen.com/en-us/case-studies/enabling-new-surgical-possibilities-high-torque-low-temperature-and-compact-size
Thank you for listening to the IntuitiveTalks Podcast.
Subscribe to the DeviceTalks Podcast Network on every major podcast platform. -
In this episode of DeviceTalks AI, Host Kayleen Brown sits down with Medtronic’s VP & Global Chief AI Officer, Rodolphe Katra, PhD, MBA, discusses the pivotal role of AI in advancing MedTech and how Medtronic is responding.
Dr. Katra walks us through Medtronic’s AccuRhythm AI, which enhances cardiac monitoring by improving arrhythmia detection and reducing false positives through cloud-based algorithms.
He also explores how AI is being integrated into Medtronic’s surgical robotics platforms to boost precision and enable personalized care.
Additionally, Dr. Katra highlights Medtronic’s AI Compass, a set of ethical guidelines ensuring AI is used securely, without bias, and in a way that improves patient outcomes. Lastly, Katra offers key insights into how Medtronic is using AI to innovate both cardiac care and surgical robotics while maintaining a strong commitment to ethical AI practices.
This conversation comes to you courtesy of our episode sponsor, AcuityMD. To learn more about AcuityMD, visit www.acuitymd.com.
Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode.
Thank you for listening to DeviceTalks AI! -
In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip device for tricuspid regurgitation.
Lesenfants highlights Abbott’s commitment to patient-centered innovation, emphasizing the importance of creating solutions that meet patients’ needs through safe and effective technologies. She also shares Abbott’s approach to expanding access to minimally invasive therapies, particularly in underserved populations worldwide, and the role of physician partnerships in advancing structural heart interventions.
Lastly, Lesenfants underscores the company’s efforts to increase diversity in clinical trials, noting the importance of intentional inclusivity across gender and ethnicity to better serve diverse patient populations.
Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/.
Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode. -
In this episode of the DeviceTalks Weekly Podcast, the DeviceTalks team wraps up the two amazing days of insights and networking at DeviceTalks West.
Tom Salemi, Kayleen Brown and Chris Newmarker welcome guests Alexis Moores, Senior Account Manager, and Steven Thill, Senior Director of Infor, which announced a partnership with NVIDIA at DeviceTalks West, the culmination of a connection forged at DeviceTalks Boston!
Thank you to Infor for sponsoring this episode of DeviceTalks Weekly. To learn how Infor supports MedTech companies visit www.infor.com.
The panel covers a few of the highlights from the event discussion surgical robotics, AI, interventional tools, women’s health.
But first, we unpack the details of PUMPKINGATE!
Thanks for listening to this episode of the DeviceTalks Weekly Podcast. -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi opens by making a strong case for MedTech people to attend DeviceTalks West, which is happening on Oct. 16-17.
Go to West.DeviceTalks.com to register.
MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers – Women’s Health, Philiips, Nyxoah, CMR Surgical, and Johnson & Johnson MedTech.
Finally, Paul Grand, CEO of MedTech Innovator, introduces DeviceTalks listeners to the five finalists who will compete for the 2024 Early-Stage Grand Prize. The winner will be voted for at the AdvaMed annual meeting in Toronto.
Thank you for listening to the DeviceTalks Weekly Podcast
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this week’s episode of the DeviceTalks Weekly Podcast, Nick Damiano, co-founder and CEO of Andromeda Surgical, previews his talk at DeviceTalks West by introducing listeners to the potential of autonomous surgery. Still early goings on, but Damiano paints and interesting picture of the future.
If you want to see the future register at West.DeviceTalks.com.
Speaking of the future, Host Tom Salemi speaks with Brody Galloway, a young MedTech professional who has turned his life’s healthcare experiences into a love of the industry and a drive to help.
Anyone who wants to help should go to EnvisionMedtech.org.
MassDevice Editor Chris Newmarker returns with his Newmarker’s Newsmakers – Surgical Robotics, Medtronic, ResMed, Layoffs and, of course, Baxter Healthcare.
Thanks for listening to the DeviceTalks Podcast Network.
Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode of this or other industry-leading podcasts. -
In this episode of Neuro Innovation Talks, the newest podcast series in the DeviceTalks Podcast Network, the DeviceTalks editors invite Johnson & Johnson MedTech Neurovascular's Head of Global Marketing, John Murray to take over the podcast studio and bring to light the stories from the pioneering neurointerventionalists who have helped shape the stroke industry.
In the first episode, Host John Murray sits down with Alejandro Berenstein, MD, Professor of Neurosurgery, Pediatrics and Radiology, Director of pediatric Cerebrovascular Surgery, Mount Sinai Health System, to discuss the incredible evolution of neurovascular surgery and its impact on modern healthcare. Dr. Berenstein shares his early inspirations, key breakthroughs, and the significant role mentors played in shaping his illustrious career. Highlighting landmark projects like the pioneering treatments for Vein of Galen Malformations (VOGM) and facial vascular anomalies, Dr. Berenstein shares the complexities and triumphs of his work. His story provides a blueprint for aspiring medical professionals and innovators, demonstrating how personal experiences, visionary thinking, and collaborative efforts can lead to groundbreaking advancements that significantly impact patient outcomes.
Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks. To learn more about how Zeus supports medical device companies, visit: www.zeusinc.com.
Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Johanna Fifi, Whitney Garrett, Howard Riina, Lillian Medina, and J. Mocco.
Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode.
Thank you for supporting the Neuro Innovation Talks podcast! -
Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West
In this podcast episode, Biolinq CEO Rich Yang reveals that he once vetoed his VC firm’s investment in the company. But something obviously changed his mind about the company’s novel approach to monitoring glucose and, hopefully, hormones and other critical elements.
If you like what you hear, join us at DeviceTalks West where Yang will give a presentation about Biolinq’s unique technology. Register now at West.DeviceTalks.com and use the code DTPOD25 to save 25%.
MassDevice Editor Chris Newmaker shares his Newmarker’s Newsmakers of the week - Route 92, Stryker Medtronic, Siemens Healthineers, Masimo and urology companies.
Thank you for listening to the DeviceTalks Weekly podcast.
Subscribe to the DeviceTalks Podcast Network. -
In this episode of Structural Heart Talks, Wayne Markowitz, General Manager and SVP, Surgical Structural Heart at Edwards Lifesciences, discussed the evolving landscape of the structural heart space, emphasizing the sharpened focus at Edwards under new leadership.
Markowitz highlights the importance of the surgical structural heart business, with a strong emphasis on innovation and collaboration with cardiac surgeons. He emphasizes Edwards' 65-year legacy in innovation driven by partnerships with the surgical community, focusing on addressing unmet patient needs. The conversation also touched on the RESILIA portfolio, featuring surgical valves and conduits, and highlights ongoing clinical trials.
Looking ahead, Markowitz shares his optimism about the future of the surgical structural heart business, emphasizing the need to bring more patients into the treatment system and the potential for growth in emerging markets.
Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8
Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode. -
In this episode of the DeviceTalks Weekly, Host Tom Salemi interviews Endiatx CEO Torrey Smith, who will be the closing keynote speaker at the DeviceTalks West conference on Oct. 16-17 at the Santa Clara Convention Center. Smith talks about his journey into MedTech. Why he quit his job. And where his dream of building a swallowable surgical robot can lead him and his company.
Register at West.DeviceTalks.com to see a demonstration of PillBot! Use the code DTPod25 to save 25%.
In this week’s Newmarker’s Newsmakers, MassDevice Editor Chris Newmarker highlights the top MedTech stories of the week from Boston Scientific, Medtronic, Synchron, Shockwave (now part of Johnson & Johnson Medtech) and Masimo.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of AbbottTalks, Jennifer Jones-McMeans, PhD, Divisional VP of Global Clinical Affairs at Abbott and Brian DeRubertis, MD, Chief, Division of Vascular & Endovascular Surgery at Weill Cornell Medical Center tackle the complexities of treating peripheral arterial disease (PAD) below the knee, particularly chronic limb-threatening ischemia (CLTI), a severe form of PAD that drastically impacts patients' quality of life and longevity.
In the episode, the two discuss Abbott's Esprit BTK System, the first-and-only FDA-approved drug-eluting resorbable scaffold for infrapopliteal CLTI. Dr. Jones-McMeans explains how Esprit BTK works by releasing a drug that prevents artery re-narrowing, crucial for maintaining sustained blood flow and promoting wound healing.
Later, they walk us through the pivotal LIFE-BTK trial, a significant milestone that demonstrated Esprit's efficacy and led to its FDA approval. They also highlight the importance of including diverse patient populations in clinical trials, particularly those disproportionately affected by PAD, such as African Americans, Latinos, Native Americans, and women. This inclusive approach not only ensures the treatment's effectiveness across varied demographics but also sets a precedent for future trials.
Thank you to Freudenberg Medical for sponsoring this episode of AbbottTalks. For more information on how Freudenberg Medical works with medical device companies, visit www.freudenbergmedical.com.
Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode. -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi chats with Managing Editor Kayleen Brown about the upcoming DeviceTalks West meeting. This week’s episode features an interview Brown did with Medtronic’s Nina Goodheart at the Women in Medtech Breakfast at DeviceTalks Boston. The conversation previews the Women in Medtech Luncheon interview featuring Cecilia Soriano, president, infusion therapies and technologies, at Baxter International. In our second interview, Salemi interviews Kirsten Carroll, CEO of Kandu Health about that company’s work to empower stroke survivors. Carroll will be speaking at DeviceTalks West.
Register at West.DeviceTalks.com to register. Use the code DTPOD25 to save 25%.
Subscribe now to the DeviceTalks Podcast Network. -
In this episode of DeviceTalks Weekly podcast, Host Tom Salemi introduces one DeviceTalks West speaker. Ray Baker, MD, vice president and chief medical officer, neuromodulation at Boston Scientific, introduces DeviceTalks Weekly listeners to Intracept, a procedure approved by the FDA to treat forms of back pain. Dr. Baker will be a speaker at DeviceTalks West on Oct. 17 where the clinical and commercial details will be discussed.
Register now at West.Devicetalks.com. Use the code mentioned in the podcast to save 25% off the price of registration.
Salemi also invites listeners to attend the Connected Health Series taking place Sept. 10-12. Sponsored by Maxon and S3 Connected Health, virtual attendees can hear from Adona Medical, Baxter, BD and Canary Medical about the future of sensors and other connected technologies.
MassDevice Editor Chris Newmarker brings another batch of Newmarker’s Newsmakers including Novocure, Medtronic, Johnson & Johnson MedTech, Edwards Lifesciences and the Big 100.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of the DeviceTalks Weekly podcast, HighRidge Medical CEO Rebecca Whitney and Executive Chairman Eric Major introduce us to the spine industry’s newest player. HighRidge combines the former spinal business of Zimmer Biomet (and later ZimVie) with seasoned executive spirit from K2M, Stryker and others. Can HighRidge compete? Will robotics and other tech be part of the story? Whitney has been on podcasts before. Listen here https://www.youtube.com/watch?v=6xtHK-FVeec and here https://youtu.be/0Ve_7NpIauQ?si=Wp-ytFHlq4ZWHeCC.
Host Tom Salemi and DeviceTalks Editor Kayleen Brown chat with MedtechVISION co-chairs Kate Stephenson, PhD, and Shelia Shah about the upcoming conference organized by the MedtechWOMEN group. A few spaces are still available. Go to MedtechWOMEN.org to register.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. -
In this episode of DeviceTalks AI, host Kayleen Brown sits down with Eigil Samset, PhD, General Manager for Cardiology Care at GE HealthCare. Dr. Samset takes us through his vast experience stretching over nearly three decades and discusses the transformative role of AI in advancing healthcare, particularly how GE HealthCare is leveraging AI to streamline and enhance cardiology care pathways.
In the episode, Dr. Samset gives us the backstory of the 2023 Caption Health acquisition and provides insights into the inspiration behind Caption AI for use in Vscan, which democratizes cardiac assessments by making them accessible to less experienced users. The conversation touches on the regulatory challenges, the importance of multi-disciplinary collaboration, and GE HealthCare's strategic approach to integrating AI – aiming to improve patient outcomes and care pathways significantly.
This conversation comes to you courtesy of our episode sponsor, DeviceTalks West. Listen to the episode for 25% OFF the registration rate: West.DeviceTalks.com.
Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode.
Thank you for listening to DeviceTalks AI! -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Tasneem Dohadwala, founding partner at Excelestar Ventures about how the small firm employs analytics, know-how, and a belief that companies are best led by diverse management teams.
MassDevice Editor Chris Newmarker returns with his Newmarker's Newsmakers including outgoing FDA CDRH Leader Jeff Shuren, the New York Times, Medtronic, Zoll Medical, Vyaire Medical, Johnson & Johnson MedTech, V-Wave, and Edwards Lifesciences.
This episode is sponsored by DeviceTalks West. Listen to the podcast to hear the discount code that will save you 25% of the price of registration. Go to West.DeviceTalks.com.
We’ll also hear a message from regulatory firm MedTech Impact Partners.
Thank you for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network. -
In this episode of Ortho Innovation Talks, Jim Lancaster, President of Global Reconstruction at Zimmer Biomet, connects his deep roots in Warsaw, Indiana—known as the orthopedic capital of the world—with his current role in shaping the region's future as a global MedTech hub with his efforts to diversify the region's medtech industry, including the partnership with Plug and Play to attract new innovations in sensor technology and augmented reality, and by driving technical innovations at Zimmer Biomet.
Additionally, Lancaster provides an in-depth look at the development of Persona IQ, the world's first smart knee system, which integrates advanced sensor technology to monitor patient recovery. He also discusses the growing importance of cementless fixation in knee implants, highlighting Zimmer Biomet's focus on enhancing implant longevity and patient outcomes. Lastly, Lancaster discusses Zimmer Biomet's role in surgical robotics, particularly the advancements brought by the Rosa robotics platform, which includes applications for knee, hip, and even shoulder surgeries.
Please join us September 10-12th for DeviceTalks's LIVE Connected Health webinar series. Register at no cost: https://event.on24.com/wcc/r/4613481/E930EFFA706588C378BEAA97824C7CE2/5516160
Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.
Thank you for listening to the Ortho Innovation Talks podcast, featuring Zimmer Biomet! -
In the inaugural episode of our newest podcast, Structural Heart Talks, we sit down with Daveen Chopra, Corporate VP and GM of Transcatheter Mitral and Tricuspid Therapies (TMTT) at Edwards Lifesciences.
In the episode, Chopra discusses the unique challenges of advancing therapies for the mitral and tricuspid valves, which have historically been more difficult to treat than the aortic valve due to their complex and varied nature. He details Edwards Lifesciences' efforts to innovate in this space with technologies like the PASCAL valve repair system and the EVOQUE tricuspid valve replacement system, the first transcatheter tricuspid valve replacement approved in both the US and Europe.
Later, Chopra explains the importance of a focused approach at Edwards Lifesciences, where the company’s specialization in structural heart disease enables deeper knowledge and more targeted innovation. The conversation also explores the intricate process of planning and executing these advanced procedures, which require close collaboration between interventional cardiologists and echocardiographers. Chopra underscores the ongoing commitment to clinical evidence and real-world outcomes as key drivers of future success in this rapidly evolving field. Looking ahead, he emphasizes the need to increase awareness, diagnosis, and treatment rates for valve diseases, noting that many patients still go untreated due to a lack of awareness.
Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8
Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode. - Näytä enemmän
